US Executive Officer Management Changes SEC — July 22, 2026

22-07-2026

GBT Technologies Inc. (GTCH) announced the expiration of Patrick Bertagna's employment agreement as Interim CEO and his resignation from the Board, effective July 15, 2026, with no disagreement with the company. Immediately prior, Bertagna appointed Minh Collins, President of wholly-owned subsidiary Cube X Media Corporation, as CEO and director, effective July 16, 2026. Collins brings over 20 years of film and TV production experience but has no prior public company leadership or technology background, marking a significant shift in management.

• · Minh Collins was appointed by the sole departing director, Patrick Bertagna, immediately before Bertagna's resignation.
• · Collins will serve as director until the 2027 Annual Meeting of Stockholders or until successor elected.
• · Collins has no family relationships with any director or executive officer and no reportable transactions under Item 404(a).
• · The company's principal executive offices are at 117 W. 9th Street, Los Angeles, CA 90015.

22-07-2026

Curtis D. Hodgson resigned from the board of Legacy Housing Corp effective July 21, 2026 at 5pm, citing personal reasons at age 72. The departure appears amicable, with Hodgson expressing gratitude and offering to remain available. No financial impact or replacement was disclosed.

• · Resignation effective July 21, 2026 at 5pm
• · Hodgson is 72 years old
• · No replacement or interim director announced
• · Hodgson offered to remain available by phone

22-07-2026

Mitesco, Inc. announced its Centcore unit's expansion into the $26 billion edge computing market with a new compact, low-power platform called 'TC/DC.' The platform targets residential, rural, and small-business deployments, with prototype testing expected in late Q3 FY2026 and initial commercial deliveries in Q1 FY2027. The company aims to scale to approximately 10,000 deployed units within 18-24 months, but the filing contains no financial results or officer changes, and the initiative is still in early development with no current revenue.

• · Prototype testing expected in late Q3 FY2026, initial commercial deliveries in Q1 FY2027.
• · Target of 10,000 deployed units within 18-24 months.
• · Edge computing market projected CAGR of 34.10% from 2025 to 2034.
• · North America held 35.70% market share in 2025.
• · 75% of data expected to be created outside central data centers by 2025.
• · Potential use in public housing to offset costs.
• · Distribution strategy leverages Robo-Agent user base of over 1 million active participants.
• · TC/DC is a hybrid, battery-driven design with multiple processor options.

22-07-2026

agilon health, inc. announced the termination of Chief Technology Officer Girish Venkatachaliah, effective August 1, 2026. He will receive cash severance of $766,063 paid over 12 months and continued equity vesting through April 30, 2027, and will provide transition consulting services through December 31, 2026. No financial results or period-over-period comparisons are included in this filing.

• · Separation effective date: August 1, 2026
• · Consulting services through December 31, 2026 for no additional cash consideration
• · Continued equity vesting through April 30, 2027 for transformation award and time-based RSUs
• · Severance Agreement includes a general release

22-07-2026

BD (Becton, Dickinson and Company) announced that Dr. Michael Garrison, EVP and President of Medical Essentials and BioPharma Systems, will retire effective October 2, 2026, after more than 20 years with the company. A search is underway for a new president of Medical Essentials, while BioPharma Systems will report directly to CEO Tom Polen, streamlining the operating model. The announcement is a routine leadership transition with no financial impact disclosed.

• · Garrison's retirement is effective Oct. 2, 2026.
• · Garrison will remain in his role through the end of the fiscal year.
• · BioPharma Systems will report directly to CEO Tom Polen going forward, reflecting its strategic importance as a growth driver.
• · Garrison held previous roles including EVP and President of BD's Medical segment, worldwide president of Medication Management Solutions, and worldwide president of Surgery.
• · Garrison joined BD in 2005.

22-07-2026

RPM International reported record fiscal 2026 fourth-quarter sales of $2.23B (+7.2% YoY) and full-year sales of $7.86B (+6.7% YoY), with record adjusted diluted EPS of $1.89 (+9.9% YoY) for Q4 and $5.53 (+4.3% YoY) for the full year. However, GAAP net income declined 2.0% in Q4 and 4.0% for the full year, and the Consumer Group posted a 0.8% organic sales decline due to soft DIY markets. The Board authorized a $700M increase to the share repurchase program, and management guided for fiscal 2027 sales growth of 3%-7% and adjusted EBITDA growth of 5%-10%.

• · The Consumer Group recorded a 0.8% organic sales decline in Q4 due to softness in DIY markets.
• · Consumer Group adjusted EBIT growth was only 2.6% YoY, the weakest among all segments, and included a $9.7M non-cash impairment charge related to the Color Group.
• · PCG adjusted EBIT was partially offset by a $3.2M bad debt expense from a customer bankruptcy.
• · Full-year GAAP net income declined 4.0% to $661.4M and diluted EPS fell 3.4% to $5.17.
• · Cash provided by operating activities was $898.7M, the second-highest in company history.
• · Total debt decreased to $2.53B from $2.65B a year ago.
• · Total liquidity improved to $1.09B from $969.1M a year ago.
• · The company returned $349.2M to stockholders through dividends and buybacks, up 7.3% YoY.
• · Fiscal 2027 first-quarter outlook calls for mid-single-digit sales and adjusted EBITDA growth across all segments.
• · Fiscal 2027 full-year outlook: sales +3% to 7%, adjusted EBITDA +5% to 10%.
• · Investor day scheduled for November 9, 2026.
• · Starting in FY27, the company will use adjusted EBITDA as its primary profit measure instead of adjusted EBIT.

22-07-2026

FirstCash Holdings, Inc. announced a CEO transition with Rick Wessel moving to Executive Chairman and Brent Stuart appointed as new CEO effective January 1, 2027. Concurrently, the Board elected Stuart as a director and Chairman Dan Feehan will retire as Chairman but remain on the board.

• · Transition effective January 1, 2027.
• · Wessel expected to serve as Executive Chairman for at least three years, subject to re-election.
• · Stuart will continue to oversee day-to-day operations as CEO.
• · Stuart has served as President & COO since September 2016 following the Cash America merger.
• · Stuart was elected to the Board effective July 22, 2026, and will not receive separate board compensation.
• · Dan Feehan will retire as Chairman on the Transition Date but remain a board member.
• · Compensation for the new roles has yet to be determined; an amendment will be filed later.

22-07-2026

Prairie Operating Co. (PROP) announced the appointment of Jennifer M. Grigsby to its Board of Directors, effective immediately. Ms. Grigsby brings over 30 years of experience in energy finance, corporate governance, and capital markets. Concurrently, Stephen Lee stepped down from the board to focus on his role as Co-CEO of Renewa. The changes are part of Prairie's ongoing strategy to strengthen board oversight and support disciplined growth.

• · Jennifer M. Grigsby currently serves on the boards of First Busey Corporation, Superior Plus Corp., and CompSource Mutual Insurance Company.
• · She previously served as Executive Vice President and CFO of Ascent Resources, and spent nearly two decades at Chesapeake Energy in senior roles including SVP, Treasurer and Corporate Secretary.
• · After Ascent, Ms. Grigsby served as Oklahoma's Secretary of Economic Administration.
• · She holds a B.S. in Accounting from Oklahoma State University, an MBA from Oklahoma City University, and is a CPA, CGMA, and holds NACD Directorship Certification.
• · Stephen Lee stepped down to focus on his growing responsibilities as Co-CEO of Renewa.

22-07-2026

First Community Corporation reported strong Q2 2026 results with net income of $7.595M, up 46.5% YoY and 38.1% linked quarter, driven by the Signature Bank acquisition and organic growth. The company also announced a leadership transition: J. Ted Nissen will retire as CEO/President of the bank effective Dec 31, 2026, with Vaughan R. Dozier becoming CEO and Joseph A. 'Drew' Painter becoming President effective Jan 1, 2027. However, total deposits declined slightly to $2.025B from $2.048B at March 31, 2026, and the past due loan ratio increased to 0.26% from 0.17% in the prior quarter, indicating some credit quality softening.

• · Net interest margin expanded to 3.51% in Q2 2026, the ninth consecutive quarter of margin expansion.
• · Loan yield increased to 6.02% in Q2 2026 from 5.94% in Q1 2026.
• · Average total deposits increased to $2.019B in Q2 2026 from $1.978B in Q1 2026, despite period-end decline.
• · Pure deposits (total deposits less CDs) were $1.702B at June 30, 2026 vs $1.727B at March 31, 2026.
• · Non-interest-bearing deposits were 26.1% of total deposits at June 30, 2026.
• · Assets under management (AUM) grew to $1.378B at June 30, 2026 from $1.130B at March 31, 2026.
• · Government Guaranteed Lending: $16.140M in loan production, $8.94M in loans sold, gain-on-sale margin of 7.50% in Q2 2026.
• · Regulatory capital ratios: Leverage 9.29%, Tier 1 Risk-Based 12.98%, Total Risk-Based 14.13% at June 30, 2026.
• · Common Equity Tier 1 ratio was 12.98% at June 30, 2026 vs 13.04% at June 30, 2025.
• · Classified loans plus OREO ratio was 2.55% of total bank regulatory risk-based capital at June 30, 2026.
• · Purchase accounting amortization on Signature Bank loan portfolio was $178K in Q2 2026 vs $437K in Q1 2026.
• · No shares were repurchased under the $7.5M buyback plan during Q2 2026.
• · J. Ted Nissen will serve in a consulting role through December 31, 2027 after retirement.
• · The CEO/President split at the bank level is effective January 1, 2027; Mike Crapps remains CEO/President of the holding company.

22-07-2026

Goosehead Insurance, Inc. filed an 8-K on July 22, 2026, reporting results of operations (Item 2.02) and an officer change (Item 5.02). The filing does not disclose specific financial metrics, the name of the departing or appointed officer, or the reason for the change. The lack of detail limits the ability to assess materiality or direction of impact.

• · Filing date: July 22, 2026
• · SEC Accession Number: 0001726978-26-000056
• · File size: 537 KB
• · Items triggered: 2.02, 5.02, 9.01
• · No specific officer name, title, or reason for departure/appointment disclosed in the provided summary.
• · No financial results or operational metrics disclosed in the provided summary.

22-07-2026

NewAmsterdam Pharma Company N.V. announced that COO Douglas Kling will resign effective August 14, 2026, to become CEO of another clinical-stage biotech company. The company expects to enter into a separation agreement and an advisor agreement with Kling for transition and advisory services related to its PREVAIL clinical trial of obicetrapib and other programs. No financial terms or performance metrics were disclosed in this filing.

• · Resignation effective date: August 14, 2026
• · Kling is leaving to become CEO of another clinical-stage biotech company
• · Advisor agreement will cover transition and advisory services for PREVAIL trial and other clinical programs
• · Material terms of separation and advisor agreements to be disclosed in a future 8-K amendment

22-07-2026

On July 20, 2026, Tracy Willis, Vice President and Chief Accounting Officer of Shenandoah Telecommunications Company, notified the company of her resignation effective August 6, 2026. James Volk, the company's Senior Vice President and Chief Financial Officer, will assume the role of principal accounting officer upon her departure. Ms. Willis' resignation was not due to any disagreement with the company regarding operations, policies, or financial disclosures.

• · Resignation effective date: August 6, 2026
• · James Volk will serve as both principal financial officer and principal accounting officer after Ms. Willis' departure
• · No disagreement cited as reason for departure

22-07-2026

Credit Acceptance Corporation announced the resignation of director Kenneth S. Booth from its board, effective July 21, 2026. Booth's departure was not due to any disagreement with the company. In connection with his resignation, the board size was reduced from six to five directors. This is a routine board change with no immediate financial impact.

22-07-2026

Ian T. Clark resigned from the board of directors of Corvus Pharmaceuticals, effective July 22, 2026, after over nine years of service. The company expressed gratitude for his contributions. No financial impact or replacement details were disclosed.

• · Resignation effective July 22, 2026, one day after notice was given.
• · Mr. Clark served on the board for over nine years.
• · No reason for resignation or immediate replacement was provided.

22-07-2026

Keros Therapeutics announced the resignation of CFO Keith Regnante, effective August 3, 2026, to pursue other opportunities, with no disagreement related to accounting or financial reporting. The company appointed Annita Tanini, Corporate Controller and VP of Finance, as interim principal financial and accounting officer effective August 4, 2026, and has commenced a search for a permanent CFO. Ms. Tanini will receive an annual base salary of $302,300 and a target bonus of 30% of base salary, while Mr. Regnante is not entitled to any additional severance beyond accrued pay and benefits.

• · Mr. Regnante's resignation is effective August 3, 2026; Ms. Tanini's appointment effective August 4, 2026.
• · Ms. Tanini has been with the company since May 2019, previously as Corporate Controller and VP of Finance.
• · Ms. Tanini holds a B.S. in finance and accounting and an M.B.A. from University of Massachusetts Lowell.
• · Mr. Regnante is not entitled to any additional severance payments beyond accrued salary and expense reimbursement.
• · The company has commenced a search for a new CFO.

22-07-2026

BayCom Corp adopted a 2026 Performance Stock Unit (PSU) Program for senior executives, with initial awards granted. PSUs vest based on a market price condition and settle 50% in stock and 50% in cash after three years. The program includes provisions for death, disability, termination, and change in control.

• · PSUs represent the right to receive one-half of one share of common stock and a cash payment equal to the Fair Market Value of one-half of one share.
• · Market Vesting Condition: volume-weighted average price per share equals or exceeds a specified threshold for 20 consecutive trading days.
• · Settlement occurs on the third anniversary of the grant date.
• · In case of death or disability, settlement within 60 days of termination.
• · Involuntary termination without cause or resignation for good reason: if market condition met, settlement within 60 days; if not, pro-rata portion retained and subject to condition.
• · All other terminations result in immediate forfeiture.
• · Change in control: if no qualifying replacement award, settlement on effective date; if replacement award, continues under replacement terms.

22-07-2026

Guidewire Software appointed Dr. Alexander Vollert to its Board of Directors, effective August 1, 2026. Dr. Vollert brings deep insurance industry expertise, having served as COO of AXA SA and CEO of AXA Group Operations, and is recognized as an AI transformation leader. The appointment is expected to support Guidewire's focus on infusing AI into its platform and applications.

• · Dr. Vollert served as CEO of AXA Germany starting in 2016 and previously held senior leadership roles at Allianz SE, including CEO of its German P&C business.
• · He spent nine years at McKinsey & Company advising financial services clients.
• · Since 2026, he has served as senior advisor to the Group Management Committee at AXA.
• · Guidewire serves more than 570 insurers in 43 countries and has completed 1,700+ successful projects.

22-07-2026

Target Corporation announced the election of Joe DePinto, former president and CEO of 7-Eleven, Inc., to its Board of Directors, effective August 1, 2026. DePinto will serve on the Infrastructure & Finance and Audit & Risk committees, bringing expertise in operations, loyalty, fresh food, and omnichannel capabilities as the company pursues growth under CEO Michael Fiddelke. The appointment is a strategic move to accelerate Target's enterprise strategy, with no negative or flat metrics reported in the filing.

• · DePinto has over three decades of leadership experience in retail and consumer products.
• · He previously served on the boards of Brinker International, Jo-Ann Stores, and OfficeMax.
• · Target operates more than 2,000 U.S. stores and serves millions of families weekly.

22-07-2026

American Healthcare REIT, Inc. (NYSE: AHR) announced leadership changes effective July 22, 2026. Jeff Hanson, previously Interim CEO since February 2026, has been named CEO while continuing as Chairman; Gabe Willhite has been elevated to President in addition to his COO role; Danny Prosky has retired as CEO after a 35-year career and remains a director and advisor; and Scott Estes has been appointed Lead Independent Director. The changes follow Prosky's medical leave and reflect a planned transition aimed at accelerating platform-enhancing strategies.

• · Jeff Hanson served as Interim CEO since February 2026 when Danny Prosky began a medical leave of absence.
• · Danny Prosky co-founded the company with Jeff Hanson and Mathieu Streiff over two decades ago.
• · Scott Estes previously served as CFO of Welltower Inc. (2006-2017) and raised over $24 billion in equity and unsecured debt capital.
• · Gabe Willhite joined the company in 2016 as Senior Vice President, Assistant General Counsel, and was promoted to COO in 2022.

22-07-2026

Intellicheck, Inc. announced the departure of Chief Technology Officer Jonathan Robins for personal family reasons, effective July 18, 2026. He will remain on unpaid leave through October 16, 2026, when his employment terminates. The company will pay for his healthcare benefits during leave and COBRA coverage through March 2027, but no financial impact or replacement plan was disclosed.

• · Mr. Robins notified the company on July 16, 2026, and his unpaid leave began July 18, 2026.
• · Final employment date is October 16, 2026.
• · Company will pay full cost of healthcare benefits (medical, dental, vision, short-term disability, long-term disability, life insurance) during unpaid leave; active health coverage ends October 31, 2026.
• · If Mr. Robins elects COBRA, company will pay full cost from November 1, 2026 through March 31, 2027.
• · Mr. Robins must execute a separation agreement releasing all claims on or about his final employment date.
• · No successor or interim CTO has been announced.

22-07-2026

Jackson Financial Inc. announced the retirement of CEO Laura Prieskorn effective end of 2026, with CFO Don Cummings succeeding her as President and CEO on October 1, 2026. Brian Walta will become EVP and CFO on the same date. The leadership transition is planned to ensure continuity, with Prieskorn serving as an advisor through December 31, 2026.

• · Laura Prieskorn has nearly 40 years with Jackson.
• · Don Cummings joined Jackson in 2020 as Chief Accounting Officer and Controller, promoted to CFO in 2024.
• · Brian Walta joined Jackson in 1997 and holds a CFA, FSA, and is a member of the American Academy of Actuaries.
• · Prieskorn led Jackson through its demerger and oversaw significant growth during her tenure.

22-07-2026

OXO, Inc. appointed Gemma Hemsworth, Fiona Callering, and Alistair Pemberton as directors on July 22, 2026. No compensation or committee assignments were provided at this time, and no material interests or arrangements were disclosed.

• · New directors have not been appointed to any Board committees.
• · New directors will not receive compensation for their service at this time.
• · No arrangements or understandings exist with any other person regarding their appointment.
• · None of the new directors have any direct or indirect material interest in any transaction requiring disclosure under Item 404(a) of Regulation S-K.

22-07-2026

Shutterstock filed an 8-K on July 22, 2026, reporting an officer change under Item 5.02, along with other events (Item 8.01) and exhibits (Item 9.01). The filing does not disclose specific names, positions, reasons, or financial metrics. No quantitative data or scheduled events are provided. The lack of detail limits analysis.

22-07-2026

NewHold Investment Corp IV announced the resignation of CFO Polly Schneck effective July 22, 2026, and the immediate appointment of John Boone as her successor. Schneck's departure is not due to any disagreement with the company, and Boone brings over a decade of public equity, private equity, and investment banking experience. Compensation arrangements for Boone have not yet been finalized.

• · Polly Schneck's resignation was effective immediately on July 22, 2026.
• · John Boone served as an Executive in Residence at Unity Partners from January 2026 to July 2026.
• · Boone was a Partner at Isomer Partners from October 2022 to March 2025.
• · Boone holds a B.S. in Commerce with Distinction from the McIntire School of Commerce at the University of Virginia.
• · There are no family relationships or reportable transactions between Boone and the company.

22-07-2026

AXT, Inc. announced the appointment of Jia-Bin Duh to its Board of Directors, effective July 16, 2026, expanding the board from five to six members. Duh brings over 30 years of senior leadership experience at Hewlett-Packard, Microsoft, and Cisco Systems, with deep expertise in Greater China markets, which is expected to support AXT's global growth and its subsidiary Tongmei in China. The filing contains no financial results or period-over-period comparisons, so no positive or negative financial metrics are present.

• · Duh served as President of Cisco Systems China from 1998 to 2005 and Corporate Vice President of Cisco Systems Inc.
• · Duh served as President of Microsoft China from 1993 to 1998.
• · Duh holds a Bachelor of Science in Control Engineering from National Chiao Tung University, an MBA from Kellogg School of Management at Northwestern University, and an MBA from Hong Kong University of Science and Technology.
• · AXT's end markets include AI/data center connectivity, 5G infrastructure, passive optical networks, LED lighting, lasers, sensors, power amplifiers for wireless devices, and satellite solar cells.
• · AXT has partial ownership in over ten companies in China producing raw materials for its manufacturing process.

22-07-2026

Trane Technologies plc announced the departure of Mingxiao (Gary) Guo, Senior Vice President and Chief Global Integrated Supply Chain Officer, effective August 1, 2026. The company entered into a Separation Agreement that includes foregoing the clawback of certain sign-on bonus payments made to Mr. Guo upon his employment commencement. The departure is stated to be not due to any disagreement with the company's operations, policies, or financial matters.

• · Departure effective date: August 1, 2026.
• · Separation Agreement includes foregoing clawback of certain sign-on bonus payments.
• · No disagreement with company operations, policies, or financial matters cited as reason for departure.

22-07-2026

Serina Therapeutics appointed Farrell Simon, Pharm. D., to its Board of Directors, effective immediately, and he will serve on the Audit and Compensation Committees. Dr. Simon brings experience from Trevi Therapeutics and Pfizer, and has supported financings totaling over $400 million. The filing also provides an overview of the SER-252 registrational study design and the POZ Platform.

• · Dr. Simon currently serves as Chief Commercial Officer at Trevi Therapeutics, Inc.
• · He spent a decade at Pfizer in senior commercial and strategic leadership roles.
• · The SER-252-1b study is a randomized, double-blind, placebo-controlled Phase 1b trial with single-ascending-dose (five cohorts of eight; n=40) and multiple-ascending-dose components (up to three cohorts of sixteen; n=48).
• · The study is being conducted across sites in the United States and Australia, with plans to expand to South Korea and Taiwan.
• · Serina has a non-exclusive license agreement with Pfizer Inc. to use Serina’s POZ polymer technology in lipid nanoparticle (LNP) drug delivery formulations.

22-07-2026

Quantum Computing Inc. (QUBT) announced the appointment of Susan Hunt as Chief Revenue Officer and the creation of a Chief Product Officer role, with former CRO Pouya Dianat transitioning to CPO. The leadership changes aim to accelerate commercial growth and strengthen product strategy as the company scales. No financial results or quantitative performance metrics were disclosed in the filing.

• · Susan Hunt has over 30 years of experience in technology executive roles.
• · Hunt previously held executive positions at Orbital Insight, Nuance Communications, LivePerson, Salesforce, and Sprint PCS.
• · Pouya Dianat will lead product vision, strategy, and management as CPO.
• · QCi operates in Arizona, California, Illinois, Indiana, Massachusetts, North Carolina, and Virginia.

22-07-2026

The Toro Company (TTC) announced a planned leadership succession: President and COO Edric C. Funk will become President and CEO effective November 1, 2026, succeeding Richard M. Olson, who will become Executive Chairman. Funk, a 30-year company veteran, has served as President and COO since September 2025. The company reported net sales of $4.5 billion in fiscal 2025.

• · Funk holds a B.S. in engineering from the University of Minnesota, an MBA from the University of Minnesota – Carlson School of Management, and a professional certificate in innovation and technology from MIT.
• · Funk serves on the boards of the National Golf Foundation and The Toro Company Foundation.
• · Olson began his career at the company as a process engineer in Windom, Minnesota.
• · During Olson's tenure as CEO, the company doubled revenue and expanded into infrastructure markets through acquisitions.
• · The company's global presence extends to more than 125 countries.

22-07-2026

Inspire Medical Systems announced the retirement of Casey M. Tansey from its Board of Directors after more than 18 years of service, effective July 30, 2026. Tansey, who represented U.S. Venture Partners and led the company's Series A financing in 2007, will be replaced by a new director to be announced in the near future. The departure is a routine board transition with no negative financial impact, though it removes a long-tenured venture capital representative.

• · Tansey led Inspire's Series A financing in November 2007.
• · The company expects to announce a new director appointment in the near future.
• · Inspire therapy is FDA-, EU MDR-, and PDMA-approved for moderate to severe obstructive sleep apnea.

22-07-2026

Astrotech Corporation (ASTC) announced the appointment of Matt Kreps to its Board of Directors, increasing board size from five to six. Mr. Kreps brings extensive capital markets and investor relations experience, which the company expects will support its strategic objectives in lunar resource development and mass-spec industry growth. The filing contains no financial results or period-over-period comparisons, so no quantitative performance metrics are available.

• · Board size increased from five to six directors.
• · Matt Kreps currently serves as SVP of Capital Markets and IR at HydroGraph Clean Power Inc. and Managing Director at Darrow Associates IR.
• · Kreps previously held senior IR roles at Shelton Group (2009-2016), Magnolia IR (2007-2009), and Halliburton (2001-2007).
• · Astrotech's subsidiaries include 1st Detect, AgLAB, Pro-Control, and EN-SCAN, Inc.
• · The company is evaluating opportunities in space, defense, industrial, and related markets.

22-07-2026

Red Cat Holdings, Inc. terminated Chief Revenue Officer Geoffrey Hitchcock for cause effective July 23, 2026, denying him severance and equity acceleration. In response, Hitchcock filed a civil complaint on July 21, 2026, alleging retaliatory termination, breach of contract, and breach of the implied covenant of good faith and fair dealing, seeking unspecified damages. The Company denies the claims and plans to defend vigorously, potentially pursuing counterclaims.

• · Termination effective July 23, 2026.
• · Board determined grounds for 'Cause' under Section 11(c) of the Employment Agreement after a hearing process.
• · Hitchcock filed a civil complaint on July 21, 2026, alleging retaliatory termination in violation of New York and Oregon law, breach of contract, and breach of the implied covenant of good faith and fair dealing.
• · The Company believes the claims are without merit and will evaluate potential counterclaims.
• · The Employment Agreement effective October 1, 2024, is incorporated by reference.